Dolby Laboratories $DLB Stock Sold by Ninety One UK Ltd

Ninety One UK Ltd decreased its holdings in shares of Dolby Laboratories (NYSE:DLB) by 4.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 315,806 shares of the electronics maker’s stock after selling 14,792 shares during the period. Ninety One UK Ltd’s holdings in Dolby Laboratories were worth $18,560,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd increased its position in Dolby Laboratories by 73,900.0% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,480 shares of the electronics maker’s stock valued at $95,000 after acquiring an additional 1,478 shares during the period. Nykredit A S purchased a new stake in Dolby Laboratories during the 2nd quarter valued at approximately $101,000. Rockefeller Capital Management L.P. lifted its position in Dolby Laboratories by 292.4% during the 4th quarter. Rockefeller Capital Management L.P. now owns 3,732 shares of the electronics maker’s stock worth $240,000 after acquiring an additional 2,781 shares during the period. Signet Financial Management LLC acquired a new stake in Dolby Laboratories during the 1st quarter worth approximately $231,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Dolby Laboratories during the 2nd quarter worth approximately $216,000. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Stock Performance

Shares of Dolby Laboratories stock opened at $60.83 on Friday. Dolby Laboratories has a one year low of $48.26 and a one year high of $69.95. The company has a market cap of $5.70 billion, a P/E ratio of 25.88 and a beta of 0.78. The firm has a fifty day moving average of $60.75 and a two-hundred day moving average of $57.56.

Dolby Laboratories (NYSE:DLB) last issued its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The business had revenue of $305.00 million for the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.78 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities analysts predict that Dolby Laboratories will post 3.23 earnings per share for the current year.

Dolby Laboratories announced that its board has authorized a share buyback plan on Thursday, July 30th that allows the company to buy back $350.00 million in shares. This repurchase authorization allows the electronics maker to reacquire up to 7% of its shares through open market purchases. Stock repurchase plans are usually a sign that the company’s management believes its shares are undervalued.

Dolby Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 19th. Investors of record on Tuesday, August 11th were given a $0.36 dividend. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a yield of 2.4%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 61.28%.

Insider Activity at Dolby Laboratories

In other Dolby Laboratories news, CAO Ryan Nicholson sold 1,183 shares of Dolby Laboratories stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total value of $77,226.24. Following the sale, the chief accounting officer owned 34,453 shares of the company’s stock, valued at approximately $2,249,091.84. The trade was a 3.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP John Couling sold 7,667 shares of Dolby Laboratories stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $58.78, for a total value of $450,666.26. Following the completion of the sale, the senior vice president directly owned 166,803 shares in the company, valued at $9,804,680.34. This represents a 4.39% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 28,889 shares of company stock worth $1,749,388 over the last 90 days. Company insiders own 37.93% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on DLB shares. Weiss Ratings upgraded Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, September 9th. Rosenblatt Securities restated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, August 28th. Finally, Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $87.50.

About Dolby Laboratories

Dolby Laboratories, Inc develops audio and imaging technologies for entertainment and communications. The company’s products and intellectual property are used in cinemas, televisions, mobile devices, personal computers, streaming platforms, gaming systems and automobiles to improve sound quality, picture quality and overall viewing experiences.

Dolby’s technology portfolio includes Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and Dolby Digital and Dolby AC-4 audio formats.